Clinical Trial Update: AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for AP-L1898 capsule in patients with lung cancer is provided, with the status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• AP-L1898

Snippet

Sponsor: Suzhou Junjing BioSciences Co., Ltd. | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN